GeoVax Enterprise Value Over E B I T D A from 2010 to 2024

GOVX Stock  USD 2.70  0.31  10.30%   
GeoVax Labs Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA will likely drop to -0.29 in 2024. During the period from 2010 to 2024, GeoVax Labs Enterprise Value Over EBITDA regression line of annual values had r-squared of  0.81 and arithmetic mean of (9,635). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(0.27)
Current Value
(0.29)
Quarterly Volatility
K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 70.5 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 324, Dividend Yield of 0.0 or PTB Ratio of 2.27. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.
  
Check out the analysis of GeoVax Labs Correlation against competitors.
For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

Latest GeoVax Labs' Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of GeoVax Labs over the last few years. It is GeoVax Labs' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeoVax Labs' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

GeoVax Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(9,635)
Geometric Mean522.45
Coefficient Of Variation(92.96)
Mean Deviation7,675
Median(13,134)
Standard Deviation8,956
Sample Variance80.2M
Range28.4K
R-Value0.90
Mean Square Error16.7M
R-Squared0.81
Slope1,799
Total Sum of Squares1.1B

GeoVax Enterprise Value Over E B I T D A History

2024 -0.29
2023 -0.27
2022 0.26
2021 -6.83
2020 -42.61
2019 -193.8
2018-13.8 K

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(0.27)(0.29)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.